TY - JOUR
T1 - Labor induction in third trimester non-viable fetus
AU - Attali, Emmanuel
AU - Kern, Guy
AU - Fouks, Yuval
AU - Reicher, Lee
AU - Many, Ariel
AU - Levin, Ishai
AU - Yogev, Yariv
AU - Cohen, Aviad
N1 - Publisher Copyright:
© 2022 Informa UK Limited, trading as Taylor & Francis Group.
PY - 2022
Y1 - 2022
N2 - Objective: We aimed to assess the efficacy of three different labor induction methods for non-viable third-trimester fetuses. Methods: This retrospective cohort study included women who had an intra-uterine fetal death or termination of pregnancy at or after 28 weeks of gestation and underwent labor induction by either transcervical foley catheter and concomitant oxytocin infusion or regular doses of vaginal Prostin© or Propess©.The primary outcome was induction to the delivery interval. Secondary outcomes included the rate of women who delivered within 24 h, time spent in the delivery room, failed induction, adverse outcomes and reported occurrence of moderate to severe pain. Results: Between January 2017 to June 2020, 107 women met the inclusion criteria. 25 women underwent induction of labor using transcervical foley catheter, 44 using Propess and 58 by Prostin©. The three groups were found to be demographically similar. The rate of women who delivered within 24 h was higher in the transcervical foley catheter group compared to the Propess© and Prostin© groups (72% vs 25% vs 29.3%, p <.001 respectively). Time to delivery was shorter among the transcervical foley catheter group compared to the Propess© and Prostin© groups (16.97 h vs 39.4 vs 39.3, p <.001 respectively). When comparing the Foley catheter group to both Propess© and Prostin©, moderate to severe pain was significantly more commonly reported in the prostaglandins groups (36.0% vs 50.0% vs 65.62%, p =.04). No difference was found in adverse outcomes, defined as intrapartum fever, post-partum hemorrhage and retained placenta. Conclusion: Cervical foley catheter with concomitant oxytocin infusion is the most effective method for induction of labor in third trimester non-viable in fetus compared to PGE2.
AB - Objective: We aimed to assess the efficacy of three different labor induction methods for non-viable third-trimester fetuses. Methods: This retrospective cohort study included women who had an intra-uterine fetal death or termination of pregnancy at or after 28 weeks of gestation and underwent labor induction by either transcervical foley catheter and concomitant oxytocin infusion or regular doses of vaginal Prostin© or Propess©.The primary outcome was induction to the delivery interval. Secondary outcomes included the rate of women who delivered within 24 h, time spent in the delivery room, failed induction, adverse outcomes and reported occurrence of moderate to severe pain. Results: Between January 2017 to June 2020, 107 women met the inclusion criteria. 25 women underwent induction of labor using transcervical foley catheter, 44 using Propess and 58 by Prostin©. The three groups were found to be demographically similar. The rate of women who delivered within 24 h was higher in the transcervical foley catheter group compared to the Propess© and Prostin© groups (72% vs 25% vs 29.3%, p <.001 respectively). Time to delivery was shorter among the transcervical foley catheter group compared to the Propess© and Prostin© groups (16.97 h vs 39.4 vs 39.3, p <.001 respectively). When comparing the Foley catheter group to both Propess© and Prostin©, moderate to severe pain was significantly more commonly reported in the prostaglandins groups (36.0% vs 50.0% vs 65.62%, p =.04). No difference was found in adverse outcomes, defined as intrapartum fever, post-partum hemorrhage and retained placenta. Conclusion: Cervical foley catheter with concomitant oxytocin infusion is the most effective method for induction of labor in third trimester non-viable in fetus compared to PGE2.
KW - Induction of labor
KW - intra-uterine fetal demise
KW - non-viable fetus
KW - oxytocin
KW - prostaglandin E2
KW - termination of pregnancy
KW - third-trimester
KW - transcervical foley catheter
UR - http://www.scopus.com/inward/record.url?scp=85139921288&partnerID=8YFLogxK
U2 - 10.1080/14767058.2022.2134768
DO - 10.1080/14767058.2022.2134768
M3 - ???researchoutput.researchoutputtypes.contributiontojournal.article???
C2 - 36244686
AN - SCOPUS:85139921288
SN - 1476-7058
VL - 35
SP - 10530
EP - 10534
JO - Journal of Maternal-Fetal and Neonatal Medicine
JF - Journal of Maternal-Fetal and Neonatal Medicine
IS - 26
ER -